A new study has shown that anti-platelet therapy could help improve outcomes for patients with aneurysmal subarachnoid hemorrhage (aSAH), a deadly form of brain bleed.
Sep 5, 2023
0
2
Children between ages 12 and 16 with a higher body mass index (BMI) are at an increased risk of developing depression symptoms, new research has found. Associations between a higher BMI and depression were weaker between ...
Sep 4, 2023
0
1
A study led by the Cicely Saunders Institute at King's College London has found that while critical care admissions for people with dementia are going down, they are increasing during the last year of life.
Sep 1, 2023
0
1
New research shows that higher levels of inflammation in the blood of patients with obesity undergoing bariatric surgery predicts poorer weight loss six months after the procedure.
Aug 31, 2023
0
63
New research led by the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London has found that selective serotonin reuptake inhibitor (SSRI) treatment for postnatal depression is associated with ...
Aug 29, 2023
0
8
Researchers from the Centre for Gene Therapy & Regenerative Medicine at King's College London, in collaboration with colleagues from University College London, have developed the first truly scalable human iPSC-neuromuscular ...
Aug 29, 2023
0
6
A new analysis in the BMJ argues that UK government opposition to drug consumption rooms is rooted in societal stigma
Aug 22, 2023
0
6
Research and development (R&D) costs for targeted oncology drugs are markedly lower if guided by a companion diagnostic strategy, but current biopharmaceutical business models suggest these savings will not be reflected in ...
Aug 21, 2023
0
1
A team of King's Informatics researchers have developed a series of prototype tools that empower communities with communication impairments to speak up. Co-designed with focus groups of complex communication needs (CCNs) ...
Aug 18, 2023
0
2
New orally available drug for spinal cord injury found to be safe and tolerable in healthy participants
Aug 10, 2023
0
5
